Tonix Pharmaceuticals (TNXP)
Commercializes TONMYA for fibromyalgia alongside branded acute migraine treatments.
$10.16
vs last close−0.43 (−4.06%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 47 days
EPS estimate
−$2.45
Revenue estimate
$15.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$9.77−$2.84−$3.86−$3.59−$3.98−$2.93−$2.44Pending
Estimate−$6.23−$3.23−$3.10−$3.59−$3.16−$2.54−$2.64−$2.45
Surprise−56.8%+12.1%−24.5%0.0%−25.9%−15.4%+7.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$2.6M$2.4M$2.0M$3.3M$5.4M$6.9M$13.5MPending
Estimate$3.2M$2.6M$2.4M$2.3M$3.0M$6.1M$7.7M$15.9M
Surprise−19.3%−6.6%−17.9%+43.0%+81.7%+12.3%+75.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$2.22 | — | — |
| Sep 2027 | −$1.78 | — | — |
| Jun 2027 | −$1.92 | — | — |
| Mar 2027 | −$2.29 | — | — |
| Dec 2026 | −$2.16 | — | — |
| Nov 2026 | −$2.45 | — | — |
| Aug 2026 | −$2.64 | −$2.44 | +7.6% |
| May 2026 | −$2.54 | −$2.93 | −15.4% |
| Mar 2026 | −$3.16 | −$3.98 | −25.9% |
| Nov 2025 | −$3.59 | −$3.59 | 0.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Apr 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$2.22 | — | — | $20.6M | — | — | — |
| Sep 2027 | −$1.78 | — | — | $30.2M | — | — | — |
| Jun 2027 | −$1.92 | — | — | $25.8M | — | — | — |
| Mar 2027 | −$2.29 | — | — | $13.4M | — | — | — |
| Dec 2026 | −$2.16 | — | — | $18.8M | — | — | — |
| Nov 9, 2026 | −$2.45 | — | — | $15.9M | — | — | — |
| Aug 10, 2026 | −$2.64 | −$2.44 | +7.6% | $7.7M | $13.5M | +75.4% | +4.7% |
| May 11, 2026 | −$2.54 | −$2.93 | −15.4% | $6.1M | $6.9M | +12.3% | +0.1% |
| Mar 12, 2026 | −$3.16 | −$3.98 | −25.9% | $3.0M | $5.4M | +81.7% | −4.1% |
| Nov 10, 2025 | −$3.59 | −$3.59 | 0.0% | $2.3M | $3.3M | +43.0% | −0.9% |
| Aug 12, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 18, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 19, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 25, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 8, 2023 | |||||||
| Mar 13, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 14, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 15, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 24, 2020 | |||||||
| Nov 8, 2019 | |||||||
| Aug 12, 2019 | |||||||
| May 13, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 13, 2018 | |||||||
| May 14, 2018 | |||||||
| Mar 12, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 14, 2017 | |||||||
| May 15, 2017 | |||||||
| Apr 17, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 5, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 4, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 10, 2015 |